Article
Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing.
BMC medical genetics - 15 Feb 2017
Guo Yiran, Hwang Liang-Dar, Li Jiankang, Eades Jason, Yu Chung Wen, Mansfield Corrine, Burdick-Will Alexis, Chang Xiao, Chen Yulan, Duke Fujiko F, Zhang Jianguo, Fakharzadeh Steven, Fennessey Paul, Keating Brendan J, Jiang Hui, Hakonarson Hakon, Reed Danielle R, Preti George
Abstract excerpt
BACKGROUND: Trimethylaminuria (TMAU) is a genetic disorder whereby people cannot convert trimethylamine (TMA) to its oxidized form (TMAO), a process that requires the liver enzyme FMO3. Loss-of-function variants in the FMO3 gene are a known cause of TMAU. In addition to the inability to metabolize TMA precursors like choline, patients often emit a characteristic odor because while TMAO is odorless, TMA has a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
